Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2009 049 324.8 |
| 96 | EP file number | EAKZ | 14 17 9393.5 |
| 97 | EP publication number | EPN | 2805950 |
| 54 | Designation/title | TI | Deuterierte Morphinanverbindungen |
| 51 | IPC main class | ICM
(ICMV) | C07D 471/08 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/439 (2006.01) |
| 22 | DE application date | DAT | Sep 18, 2009 |
| 96 | EP application date | EAT | Sep 18, 2009 |
| 43 | Date of first publication | OT | Nov 26, 2014 |
| Date of publication of grant | PET | Nov 8, 2017 |
| 71/73 | Applicant/owner | INH | CONCERT PHARMACEUTICALS, INC., Lexington, Mass., US |
| 72 | Inventor | IN | Graham, Philip B., CarlisleMA 01741, US; Silvermann, I. Robert, ArlingtonMA 02474, US |
| Address for service | | Marks & Clerk (Luxembourg) LLP, 1017 LUXEMBOURG, LU |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
98511 P
Sep 19, 2008
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002805950
Searchable text:
EP000002805950
Original document:
EP000002805950B1
Searchable text:
EP000002805950B1 |
| 43 | Date of first publication | EVT | Nov 26, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Jan 9, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 23, 2022
(Show all update days)(Hide all update days)- Jun 23, 2022; May 17, 2022; Oct 6, 2020; Oct 9, 2019; Aug 14, 2019; May 23, 2019; Nov 8, 2018; Oct 5, 2018; Oct 4, 2018; Dec 1, 2017; Nov 9, 2017; Apr 20, 2017; Jan 12, 2017
- Historical data not available for this/these date(s)
- Jan 9, 2015
- Date of the first transfer into DPMAregister
|
